DD210040A5 - Verfahren zur herstellung von 4-phenyl-chinazolin-derivaten - Google Patents

Verfahren zur herstellung von 4-phenyl-chinazolin-derivaten Download PDF

Info

Publication number
DD210040A5
DD210040A5 DD82244148A DD24414882A DD210040A5 DD 210040 A5 DD210040 A5 DD 210040A5 DD 82244148 A DD82244148 A DD 82244148A DD 24414882 A DD24414882 A DD 24414882A DD 210040 A5 DD210040 A5 DD 210040A5
Authority
DD
German Democratic Republic
Prior art keywords
group
reaction
amine
preparation
phenyl
Prior art date
Application number
DD82244148A
Other languages
German (de)
English (en)
Inventor
Andre Hallot
Kathleen Biziere
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DD210040A5 publication Critical patent/DD210040A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DD82244148A 1981-10-21 1982-10-20 Verfahren zur herstellung von 4-phenyl-chinazolin-derivaten DD210040A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119767A FR2514765A1 (fr) 1981-10-21 1981-10-21 Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
DD210040A5 true DD210040A5 (de) 1984-05-30

Family

ID=9263248

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82244148A DD210040A5 (de) 1981-10-21 1982-10-20 Verfahren zur herstellung von 4-phenyl-chinazolin-derivaten

Country Status (24)

Country Link
US (1) US4499092A (sv)
EP (1) EP0079810B1 (sv)
JP (1) JPS5888369A (sv)
KR (1) KR880001077B1 (sv)
AT (1) ATE17576T1 (sv)
AU (1) AU551938B2 (sv)
CA (1) CA1236102A (sv)
CS (1) CS229692B2 (sv)
DD (1) DD210040A5 (sv)
DE (1) DE3268699D1 (sv)
DK (1) DK156063C (sv)
ES (1) ES8307226A1 (sv)
FI (1) FI73982C (sv)
FR (1) FR2514765A1 (sv)
GR (1) GR76535B (sv)
HU (1) HU187579B (sv)
IE (1) IE53653B1 (sv)
IL (1) IL66960A0 (sv)
NO (1) NO164167C (sv)
NZ (1) NZ202237A (sv)
PT (1) PT75667B (sv)
SU (1) SU1299511A3 (sv)
YU (1) YU43528B (sv)
ZA (1) ZA827516B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521144A1 (fr) * 1982-02-08 1983-08-12 Sanofi Sa Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
EP0664128A4 (en) * 1992-10-07 1997-12-17 Sumitomo Pharma PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
EP1618094B1 (en) * 2003-04-30 2007-09-05 The Institutes for Pharmaceutical Discovery, LLC Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
EP1685115A1 (en) * 2003-11-03 2006-08-02 Warner-Lambert Company LLC Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
AU2006263924A1 (en) * 2005-06-27 2007-01-04 F. Hoffmann-La Roche Ag Chloro-substituted guanidines
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
KR20140054433A (ko) 2006-11-22 2014-05-08 스미또모 가가꾸 가부시끼가이샤 사이토카이닌 신호전달을 저해할 수 있는 물질

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA894239A (en) * 1972-02-29 Pfizer Inc. Nitrogen heterocycles
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3509141A (en) * 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation

Also Published As

Publication number Publication date
HU187579B (en) 1986-01-28
FI73982B (fi) 1987-08-31
FI73982C (sv) 1987-12-10
EP0079810A1 (fr) 1983-05-25
FR2514765A1 (fr) 1983-04-22
CS229692B2 (en) 1984-06-18
ES516694A0 (es) 1983-07-01
JPS5888369A (ja) 1983-05-26
AU8962882A (en) 1983-04-28
KR840001968A (ko) 1984-06-07
FI823580L (fi) 1983-04-22
ES8307226A1 (es) 1983-07-01
EP0079810B1 (fr) 1986-01-22
DK156063C (da) 1989-11-13
YU43528B (en) 1989-08-31
NO164167B (no) 1990-05-28
IL66960A0 (en) 1983-02-23
US4499092A (en) 1985-02-12
NO823491L (no) 1983-04-22
IE822447L (en) 1983-04-21
NO164167C (no) 1990-09-05
DK156063B (da) 1989-06-19
CA1236102A (en) 1988-05-03
FI823580A0 (fi) 1982-10-20
AU551938B2 (en) 1986-05-15
DK465182A (da) 1983-04-22
IE53653B1 (en) 1989-01-04
ATE17576T1 (de) 1986-02-15
NZ202237A (en) 1985-08-30
FR2514765B1 (sv) 1984-04-06
YU223382A (en) 1984-10-31
KR880001077B1 (ko) 1988-06-22
DE3268699D1 (en) 1986-03-06
PT75667B (fr) 1985-01-11
ZA827516B (en) 1983-08-31
GR76535B (sv) 1984-08-10
PT75667A (fr) 1982-11-01
SU1299511A3 (ru) 1987-03-23

Similar Documents

Publication Publication Date Title
DE3144183C2 (sv)
EP0005205A1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3011490A1 (de) 4-amino-3-chinolincarbonsaeure und derivate davon, verfahren zur herstellung dieser verbindungen und ihreverwendung
CH625522A5 (sv)
DE2504565A1 (de) Neue derivate von 1h-imidazo(4,5-c) pyridin-7-carboxylsaeuren und -saeureestern
DE2835004C2 (sv)
DD210040A5 (de) Verfahren zur herstellung von 4-phenyl-chinazolin-derivaten
DE2604748A1 (de) Aminoderivate von imidazo(4,5-b) pyridinen
DE2719211A1 (de) Arylalkylpiperidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD216014A5 (de) Verfahren zur herstellung von verbindungen mit einem heterocyclischen distickstoffkern
DE2258036A1 (de) Verfahren zur herstellung von benzo eckige klammer auf b eckige klammer zu thiophen-derivaten
DE2919800A1 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
EP0288048A2 (de) Benzo- und Thieno-3,4-dihydro-pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3438244C2 (sv)
DE3807084A1 (de) Neue benzimidazo(1,2-c)chinazoline, ihre herstellung und verwendung
DE2134880C3 (de) Thieno-pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2456098C3 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0094038A1 (de) 3-Amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre Herstellung und ihre Verwendung
EP0233483A2 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DE2730593A1 (de) Neue aminoalkoxybenzofurane, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
DD209457A5 (de) Verfahren zur herstellung von 4-piperazinyl-4-phenyl-chinazolin-derivaten
DE2215440A1 (de) l.S-Dihydro-S-hydroxyo-phenyWH-i^benzodiazepin-2-on-substituierteDiaminoacetate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2736652C2 (sv)
DE1470139B2 (de) 5,11-Dihydrodlbenz eckige Klammer auf b,e eckige Klammer zu-1,4-oxazepine und Verfahren zu ihrer Herstellung